Streamlining Oncology Imaging Prior Auth for Rapid Cancer Care

Klivira automates oncology imaging prior auth, accelerating critical diagnostic and surveillance scans for cancer patients by integrating directly with EMRs and payer benefit managers.

For revenue cycle directors and prior authorization coordinators in oncology, managing imaging prior authorizations is a high-stakes, high-volume challenge. Delays in advanced imaging for staging, treatment response assessment, or surveillance can directly impact patient outcomes and operational efficiency. Klivira provides a purpose-built solution to navigate the complexities of oncology imaging prior auth.

The Unique Demands of Oncology Imaging Prior Auth

Oncology patients frequently require advanced imaging such as PET/CT, MRI, and molecular imaging for diagnosis, staging, and ongoing surveillance. Each of these high-cost procedures often triggers a prior authorization event, frequently routed through specialized radiology benefit managers (RBMs) like eviCore, NIA Magellan, or AIM Specialty Health. The urgency of cancer care means that any PA delay directly impacts treatment timelines, making efficient processing critical.

Common PA-Triggering Imaging in Oncology

PET/CT scans for initial staging and response assessment.
Advanced MRI for brain, liver, or bone metastases.
Tumor-specific molecular imaging.
CT scans for treatment planning and surveillance.
Nuclear medicine scans for specific cancer types.

Navigating Payer and RBM Requirements for Oncology Imaging

Imaging prior authorizations in oncology typically involve rigorous medical necessity reviews, often based on ACR Appropriateness Criteria. Payers and RBMs require detailed clinical documentation, including diagnosis confirmation, tumor staging, prior treatment history, and rationale for the specific imaging modality. Manual workflows for identifying the correct RBM, submitting via disparate portals, and managing peer-to-peer reviews introduce significant friction and delay.

Klivira's Automated Workflow for Oncology Imaging PA

Klivira integrates seamlessly into your EMR workflow to automate oncology imaging prior auth. At the point of order entry, our platform uses CDS Hooks to detect PA requirements, identify the correct payer or RBM (e.g., eviCore, NIA Magellan, AIM Specialty Health), and initiate the submission process. We leverage FHIR data to pre-populate forms, reducing manual data entry and ensuring all required clinical documentation, often guided by NCCN Clinical Practice Guidelines, is included.

Key Klivira Capabilities for Oncology Imaging PA

EMR-side detection of imaging PA requirements at order entry via Da Vinci CRD.
Automated routing to payer portals, X12 278 endpoints, or specific RBM platforms (eviCore, NIA Magellan, AIM).
Pre-submission evaluation against ACR Appropriateness Criteria to proactively surface potential denials.
Recommendation of alternative imaging options to clinicians at order entry.
Integrated peer-to-peer scheduling for clinical denials, minimizing oncologist administrative burden.
Concurrent PA tracking for multiple imaging events across a patient's cancer treatment course.

Accelerating Time-to-Scan for Oncology Patients

By automating the entire imaging prior authorization lifecycle, Klivira significantly reduces administrative burden and accelerates time-to-scan for oncology patients. This operational efficiency directly supports improved patient care pathways, ensuring critical diagnostic and surveillance imaging proceeds without unnecessary delays. Our platform is designed to handle the unique cadence of oncology treatment, where frequent regimen changes and ongoing monitoring necessitate rapid and accurate PA processing.

Frequently asked questions

How does Klivira handle specific Radiology Benefit Managers (RBMs) for oncology imaging?

Klivira's platform automatically identifies the correct RBM (e.g., eviCore, NIA Magellan, AIM Specialty Health) based on the payer and patient plan. It then routes the imaging prior authorization request directly to the appropriate RBM portal or API, ensuring submissions comply with their specific requirements and data fields, streamlining a historically complex workflow.

Does Klivira integrate with NCCN guidelines for oncology imaging prior authorizations?

While NCCN Clinical Practice Guidelines primarily inform medical necessity for treatments, Klivira's platform can be configured to leverage NCCN-aligned logic to support the clinical rationale for imaging requests. It ensures that the documentation submitted for imaging PAs aligns with the overall treatment plan and diagnostic needs as supported by recognized clinical guidelines.

How does Klivira address the urgency of oncology imaging for cancer patients?

Klivira significantly reduces PA turnaround times by automating requirement detection, data extraction from the EMR, and submission to payers or RBMs. This automation minimizes manual delays, allowing clinics to obtain approvals faster and schedule critical imaging studies more promptly, directly supporting the time-sensitive nature of cancer diagnosis and treatment.

What EMR data does Klivira use for oncology imaging PA submissions?

Klivira extracts relevant clinical data from your EMR, including ICD-10 diagnoses, patient demographics, prior imaging history, and clinician notes. This data is then used to automatically populate the necessary fields for imaging PA requests, ensuring comprehensive and accurate submissions to payers and RBMs, adhering to standards like Da Vinci CRD and PAS.

Can Klivira help prevent denials for oncology imaging prior authorizations?

Yes, Klivira incorporates pre-submission checks against common medical necessity frameworks like ACR Appropriateness Criteria. If an order doesn't meet the criteria, the system can flag it and recommend alternative imaging or additional documentation to the clinician at the point of order, significantly reducing the likelihood of a denial and preventing delays.